IP Library Granted Patent US 7,018,396
Granted Patent B2
US 7,018,396 · App. 09/924,156 · Granted Mar 28, 2006

Method of treating acne

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,018,396
App. No.
09/924,156
Granted
Mar 28, 2006
Kind
B2
Abstract

A method of selectively enhancing photothermal sebaceous gland disruption and treatment of acne is disclosed. The method provides for alleviation of the acne symptoms as well as preventing acne recurrence and new acne from occurring.

Claims (23)

1. A method of treating a patient who has an unwanted skin condition associated with the production of sebum, the method comprising:

generating, on the patient's skin, a target region having substantially clear pores, wherein generating the target region comprises applying an acidic composition to an area of the patient's skin and heating or mechanically abrading the area;

topically administering an exogenous chromophore onto the target region, wherein the chromophore absorbs laser light having a wavelength between about 700 nm to about 1200 nm; and

irradiating the target region with laser light having a wavelength between about 700 nm to about 1200 nm form a time sufficient to inhibit subsequent sebum production within the target region.

2. The method of claim 1 , wherein applying an acidic composition to an area of the patient's skin comprises topically applying a glycolic acid solution or a salicylic acid preparation to the area.

3. The method of claim 2 , wherein the acidic solution is a glycolic acid solution and the method further comprises the step of neutralizing the glycolic acid solution by administering at least one neutralizing agent to the target region.

4. The method of claim 3 , wherein the neutralizing agent is water, a sodium bicarbonate solution, or GLYTONE®.

5. The method of claim 1 , wherein the glycolic acid solution is a 70% glycolic acid solution.

6. The method of claim 1 , further comprising, prior to the step of generating the target region, a step of wiping an area of the patient's skin with alcohol, wherein the area subjected to wiping is substantially the same as the target region.

7. The method of claim 1 , wherein the unwanted skin condition is acne.

8. The method of claim 1 , wherein the chromophore is a lipophilic chromophore.

9. The method of claim 8 , wherein the lipophilic chromophore is beta-carotene.

10. The method of claim 1 , wherein the chromophore is a dye.

11. The method of claim 10 , wherein the dye is indocyanine green, Rhodamine B, or cresyl violet.

12. The method of claim 1 , wherein the chromophore is combined with a lipophilic carrier.

13. The method of claim 12 , wherein the lipophilic carrier is a liposome.

14. The method of claim 12 , wherein the lipophilic carrier is a lipid suspension.

15. The method of claim 14 , wherein the lipid suspension comprises an oil or a surfactant.

16. The method of claim 15 , wherein the oil is a sunflower oil, an olive oil, or a safflower oil.

17. The method of claim 1 , wherein the wavelength is between about 750 nm and about 850 nm.

18. The method of claim 1 , wherein the wavelength is between about 800 nm and about 820 nm.

19. The method of claim 1 , wherein irradiating the target region with laser light comprises irradiating the target region with laser light having a pulse duration of about 200 msec.

20. The method of claim 1 , wherein irradiating the target region with laser light comprises irradiating the target region with laser light having a pulse duration of about 500 msec.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 1, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066723/0227 →
TERMINATION AND RELEASE OF PATENTS Recorded Feb 29, 2024
From: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066707/0957 →
ABL NOTICE AND CONFIRMATION OF GRANT OFSECURITY INTEREST IN PATENTS Recorded Jan 12, 2024
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 066222/0937 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jan 7, 2020
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 051496/0579 →
RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Dec 30, 2019
From: BANK OF AMERICA, N.A.
To: CYNOSURE, LLC
Reel/Frame 051447/0536 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
CHANGE OF NAME Recorded Mar 22, 2019
From: CYNOSURE, INC.
To: CYNOSURE, LLC
Reel/Frame 048678/0928 →
SECURITY INTEREST Recorded May 3, 2017
From: CYNOSURE, INC.; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 042261/0911 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2005
From: MCMILLAN, KATHLEEN
To: NEW ENGLAND MEDICAL CENTER HOSPITALS, INC.
Reel/Frame 016219/0798 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2002
From: SIERRA, RAFEL A.; MIRKOW, MIRKO; LLOYD, JENNIFER R.
To: CYNOSURE, INC.
Reel/Frame 012870/0315 →